과제정보
Authors are the thankful to the Probecell: Scientific Writing Services for editing and proofreading of this article.
참고문헌
- Cortes-Justo E, Garfias-Ramirez SH, Vilches-Flores A. The function of the endocannabinoid system in the pancreatic islet and its implications on metabolic syndrome and diabetes. Islets. 2023;15(1):1-11. https://doi.org/10.1080/19382014.2022.2163826
- Fujiwara Y, Eguchi S, Murayama H, Takahashi Y, Toda M, Imai K, et al. Relationship between diet/exercise and pharmacotherapy to enhance the GLP-1 levels in type 2 diabetes. Endocrinol Diabetes Metab. 2019;2(3):e00068.
- Ganesan K, Rana MBM, Sultan S. Oral hypoglycemic medications. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
- Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmacother. 2020;131:110708.
- Shinoyama H, Anderson N, Furuta H, Mochizuki A, Nomura Y, Singh R, et al. Chrysanthemum biotechnology. In: Teixeira da Silva JA, editor. Floriculture, ornamental and plant biotechnology: advances and topical issues (Vol. II). Isleworth: Global Science Books; 2006. p. 140-63.
- Kim YJ, Kim HK, Lee HS. Hypoglycemic effect of standardized Chrysanthemum zawadskii ethanol extract in high-fat diet/ streptozotocin-induced diabetic mice and rats. Food Sci Biotechnol. 2018;27(6):1771-9. https://doi.org/10.1007/s10068-018-0399-9
- Shao Y, Sun Y, Li D, Chen Y. Chrysanthemum indicum L.: a comprehensive review of its botany, phytochemistry and pharmacology. Am J Chin Med. 2020;48(4):871-97. https://doi.org/10.1142/S0192415X20500421
- Liang WL, Gong D, Zhang WK. The composition of chrysanthemum extracts and their pharmacological functions. STE-Medicine. 2021;2(5):e69.
- Akmal M, Wadhwa R. Alpha glucosidase inhibitors. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
- Yamakage H, Konishi Y, Muranaka K, Hotta K, Miyamoto Y, Morisaki H, et al. Association of protein tyrosine phosphatase 1B gene polymorphism with the effects of weight reduction therapy on bodyweight and glycolipid profiles in obese patients. J Diabetes Investig. 2021;12(8):1462-70. https://doi.org/10.1111/jdi.13492
- Sakaguchi M, Okagawa S, Okubo Y, Otsuka Y, Fukuda K, Igata M, et al. Phosphatase protector alpha4 (α4) is involved in adipocyte maintenance and mitochondrial homeostasis through regulation of insulin signaling. Nat Commun. 2022;13(1):6092.
- Zhang X, Tian J, Li J, Huang L, Wu S, Liang W, et al. A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance. Br J Pharmacol. 2016;173(12):1939-49. https://doi.org/10.1111/bph.13483
- OECD. Test No. 425: acute oral toxicity: up-and-down procedure. Paris: OECD; 2022.
- Barik R, Jain S, Qwatra D, Joshi A, Tripathi GS, Goyal R. Antidiabetic activity of aqueous root extract of Ichnocarpus frutescens in streptozotocin-nicotinamide induced type-II diabetes in rats. Indian J Pharmacol. 2008;40(1):19-22. https://doi.org/10.4103/0253-7613.40484
- Gershell L. Type 2 diabetes market. Nat Rev Drug Discov. 2005;4(5):367-8. https://doi.org/10.1038/nrd1723
- Koren S, Fantus IG. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab. 2007;21(4):621-40. https://doi.org/10.1016/j.beem.2007.08.004
- Derosa G, Maffioli P. α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci. 2012;8(5):899-906. https://doi.org/10.5114/aoms.2012.31621
- Kuk EB, Jo AR, Oh SI, Sohn HS, Seong SH, Roy A, et al. AntiAlzheimer's disease activity of compounds from the root bark of Morus alba L. Arch Pharm Res. 2017;40(3):338-49. https://doi.org/10.1007/s12272-017-0891-4